(Q41687237)

English

Variations in serum sphingolipid levels associate with liver fibrosis progression and poor treatment outcome in hepatitis C virus but not hepatitis B virus infection

scientific article published on 28 January 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 October 2017

Variations in serum sphingolipid levels associate with liver fibrosis progression and poor treatment outcome in hepatitis C virus but not hepatitis B virus infection (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 October 2017

1 reference

based on heuristic

inferred from title

Hepatitis B virus

1 reference

based on heuristic

inferred from title

Hepatitis C virus

1 reference

based on heuristic

inferred from title

9

object named as

Stefan Zeuzem

1 reference

Europe PubMed Central

PubMed publication ID

7 October 2017

author name string

Georgios Grammatikos

1

1 reference

Europe PubMed Central

PubMed publication ID

7 October 2017

Nerea Ferreiros

2

1 reference

Europe PubMed Central

PubMed publication ID

7 October 2017

Dimitra Bon

3

1 reference

Europe PubMed Central

PubMed publication ID

7 October 2017

Stephanie Schwalm

4

1 reference

Europe PubMed Central

PubMed publication ID

7 October 2017

Julia Dietz

5

1 reference

Europe PubMed Central

PubMed publication ID

7 October 2017

Caterina Berkowski

6

1 reference

Europe PubMed Central

PubMed publication ID

7 October 2017

Daniel Fitting

7

1 reference

Europe PubMed Central

PubMed publication ID

7 October 2017

Eva Herrmann

8

1 reference

Europe PubMed Central

PubMed publication ID

7 October 2017

Christoph Sarrazin

10

1 reference

Europe PubMed Central

PubMed publication ID

7 October 2017

Josef Pfeilschifter

11

1 reference

Europe PubMed Central

PubMed publication ID

7 October 2017

language of work or name

0 references

publication date

28 January 2015

1 reference

Europe PubMed Central

PubMed publication ID

7 October 2017

1 reference

Europe PubMed Central

PubMed publication ID

7 October 2017

61

1 reference

Europe PubMed Central

PubMed publication ID

7 October 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

7 October 2017

812-822

1 reference

Europe PubMed Central

PubMed publication ID

7 October 2017

Report from a Viral Hepatitis Policy Forum on implementing the WHO Framework for Global Action on viral hepatitis in North Asia.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27587

21 January 2018

The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27587

21 January 2018

Non-invasive evaluation of liver fibrosis using transient elastography

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27587

21 January 2018

A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27587

21 January 2018

Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27587

21 January 2018

The metabolism and function of sphingolipids and glycosphingolipids.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27587

21 January 2018

Lipids as targets for novel anti-inflammatory therapies

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27587

21 January 2018

Physiological and pathophysiological aspects of ceramide

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27587

21 January 2018

The roles of neutral sphingomyelinases in neurological pathologies

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27587

21 January 2018

The equilibrium between long and very long chain ceramides is important for the fate of the cell and can be influenced by co-expression of CerS.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27587

21 January 2018

Long chain ceramides and very long chain ceramides have opposite effects on human breast and colon cancer cell growth

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27587

21 January 2018

Changes in membrane biophysical properties induced by sphingomyelinase depend on the sphingolipid N-acyl chain

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27587

21 January 2018

Ceramide synthase 5 mediates lipid-induced autophagy and hypertrophy in cardiomyocytes

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27587

21 January 2018

Sphingolipid signalling and liver diseases

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27587

21 January 2018

Critical Role of Virion-Associated Cholesterol and Sphingolipid in Hepatitis C Virus Infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27587

21 January 2018

Self-enhancement of hepatitis C virus replication by promotion of specific sphingolipid biosynthesis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27587

21 January 2018

Ceramide enrichment of the plasma membrane induces CD81 internalization and inhibits hepatitis C virus entry.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27587

21 January 2018

Hepatocytes traffic and export hepatitis B virus basolaterally by polarity-dependent mechanisms

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27587

21 January 2018

Serine palmitoyltransferase inhibitor suppresses HCV replication in a mouse model

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27587

21 January 2018

Host sphingolipid biosynthesis is a promising therapeutic target for the inhibition of hepatitis B virus replication

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27587

21 January 2018

Blood sphingolipidomics in healthy humans: impact of sample collection methodology

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27587

21 January 2018

Serum ceramides increase the risk of Alzheimer disease: the Women's Health and Aging Study II.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27587

21 January 2018

Plasma ceramides are elevated in obese subjects with type 2 diabetes and correlate with the severity of insulin resistance

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27587

21 January 2018

Ceramides and cardiac function in children with chronic kidney disease.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27587

21 January 2018

Elevation of ceramide in serum lipoproteins during acute phase response in humans and mice: role of serine–palmitoyl transferase

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27587

21 January 2018

Inhibition of ceramide de novo synthesis with myriocin affects lipid metabolism in the liver of rats with streptozotocin-induced type 1 diabetes.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27587

21 January 2018

Role of ceramides in nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27587

21 January 2018

Serum acid sphingomyelinase is upregulated in chronic hepatitis C infection and non alcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27587

21 January 2018

Improved responses to pegylated interferon alfa-2b and ribavirin by individualizing treatment for 24-72 weeks

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27587

21 January 2018

Plasma concentration of bioactive lipid mediator sphingosine 1-phosphate is reduced in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27587

21 January 2018

Sphingosine-1-phosphate: a Janus-faced mediator of fibrotic diseases

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27587

21 January 2018

A serine palmitoyltransferase inhibitor blocks hepatitis C virus replication in human hepatocytes

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27587

21 January 2018

Characterization of the hepatitis C virus RNA replication complex associated with lipid rafts

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27587

21 January 2018

Hepatitis C virus hijacks host lipid metabolism

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27587

21 January 2018

Hepatitis C virus and host cell lipids: an intimate connection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27587

21 January 2018

Temporal Proteome and Lipidome Profiles Reveal Hepatitis C Virus-Associated Reprogramming of Hepatocellular Metabolism and Bioenergetics

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27587

21 January 2018

Gene expression profiling indicates the roles of host oxidative stress, apoptosis, lipid metabolism, and intracellular transport genes in the replication of hepatitis C virus

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27587

21 January 2018

Mechanisms of hepatic fibrogenesis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27587

21 January 2018

Apoptosis: a mechanism of acute and chronic liver injury

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27587

21 January 2018

Chain length-specific properties of ceramides

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27587

21 January 2018

A critical role for ceramide synthase 2 in liver homeostasis: II. insights into molecular changes leading to hepatopathy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27587

21 January 2018

Insulin resistance plays a significant role in liver fibrosis in chronic hepatitis C and in the response to antiviral therapy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27587

21 January 2018

Insulin resistance is associated with chronic hepatitis C virus infection and fibrosis progression [corrected].

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27587

21 January 2018

A ceramide-centric view of insulin resistance

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27587

21 January 2018

Ablation of very long acyl chain sphingolipids causes hepatic insulin resistance in mice due to altered detergent-resistant membranes.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27587

21 January 2018

Ablation of ceramide synthase 2 causes chronic oxidative stress due to disruption of the mitochondrial respiratory chain

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27587

21 January 2018

FIB-4: An inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotest

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27587

7 January 2021

based on heuristic

inferred from DOI database lookup

Apoptosis in liver disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27587

7 January 2021

based on heuristic

inferred from DOI database lookup

Comprehensive proteomic analysis of host cell lipid rafts modified by HBV infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27587

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/HEP.27587

1 reference

Europe PubMed Central

PubMed publication ID

7 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41687237&oldid=1925909151"